- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| Fr | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Mi | IMAC Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 22.11. | IMAC Holdings receives non-compliance notice from Nasdaq | 2 | Seeking Alpha | ||
| 22.11. | IMAC Holdings, Inc.: IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q | 66 | GlobeNewswire (Europe) | FRANKLIN, TN, Nov. 22, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing... ► Artikel lesen | |
| 22.11. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 15.11. | IMAC Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 14.11. | Imac Holdings-Aktie erreicht 52-Wochen-Tief bei 1,02 US-Dollar | 2 | Investing.com Deutsch | ||
| 14.11. | Imac Holdings stock hits 52-week low at $1.02 | 1 | Investing.com | ||
| 14.11. | IMAC Holdings, Inc.: IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c) | 77 | GlobeNewswire (Europe) | FRANKLIN, TN, Nov. 14, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it has received an exception from the Listing Qualifications Staff... ► Artikel lesen | |
| 13.11. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 23.10. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.09. | IMAC Holdings welcomes Jeffrey Busch to its Board of Directors | 2 | Investing.com | ||
| 25.09. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.09. | Imac Holdings stock hits 52-week low at $1.2 amid market challenges | 1 | Investing.com | ||
| 19.09. | IMAC Holdings, Inc.: IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology | 1 | GlobeNewswire (USA) | ||
| 13.09. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.08. | IMAC Holdings receives notification of deficiency from Nasdaq | 1 | Seeking Alpha | ||
| 23.08. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.08. | IMAC Holdings, Inc.: IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q | 383 | GlobeNewswire (Europe) | FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing... ► Artikel lesen | |
| 30.07. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,998 | -3,67 % | Plus Therapeutics Inc.: Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer Symposium | ||
| ASENSUS SURGICAL | 0,305 | 0,00 % | KARL STORZ akquiriert den US-amerikanischen Robotik-Spezialisten Asensus Surgical | Tuttlingen / Research Triangle Park, USA (ots) - Das familiengeführte und international agierende Medizintechnikunternehmen KARL STORZ gibt die Akquisition des innovativen Robotik-Spezialisten Asensus... ► Artikel lesen | |
| MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve president, CEO Preiner resigns | ||
| LIFEWARD | 1,470 | -1,34 % | Lifeward-Direktor Joseph Turk erwirbt Unternehmensaktien im Wert von 10.140 US-Dollar | ||
| EKSO BIONICS | 0,592 | -0,34 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Announces Third Quarter 2024 Financial Results | SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today... ► Artikel lesen | |
| IMUNON | 0,810 | +1,25 % | Imunon, Inc.: IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer | Company aligned with FDA on CMC strategy and requirements in preparation of Phase 3 pivotal trial of IMNN-001 Vertical integration of major components assures a high-quality, commercially viable future... ► Artikel lesen | |
| ROCKWELL MEDICAL | 1,916 | -3,67 % | Aktien New York Ausblick: Verluste erwartet - Konjunkturdaten und Fed im Fokus | NEW YORK (dpa-AFX) - An den US-Börsen bahnt sich am Dienstag für den Dow Jones Industrial der neunte Schwächetag in Folge an. Die überwiegend mit Technologiewerten bestückte Nasdaq dürfte nach einem... ► Artikel lesen | |
| AVINGER | 0,490 | -31,47 % | Avinger Inc - 8-K, Current Report | ||
| VIRIDIAN THERAPEUTICS | 18,000 | -1,64 % | Viridian Therapeutics (NASDAQ:VRDN) Shares Gap Down - Time to Sell? | ||
| SINTX TECHNOLOGIES | 3,870 | +5,74 % | SINTX Technologies, Inc.: SINTX Technologies Provides Positive Strategic Business Update for Q3 2024 | Salt Lake City, UT, Nov. 14, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), an advanced ceramics company that develops and commercializes materials, components... ► Artikel lesen | |
| AETHLON MEDICAL | 0,550 | +0,92 % | AETHLON MEDICAL INC - 8-K, Current Report | ||
| STAGEZERO LIFE SCIENCES | 0,028 | 0,00 % | Stagezero Life Sciences Ltd (2): Stagezero loses $1.43-million (U.S.) in nine months | ||
| NEURONETICS | 1,318 | +5,95 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MALVERN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company") today announced the granting of inducement awards to new employees as described below. In accordance... ► Artikel lesen | |
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
| HVIVO | 0,216 | -0,92 % | hVIVO reports breakthrough in COVID-19 biomarker study |
IMAC HOLDINGS INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,050 (+4,27 %) liegt der Kurs bei 1,220 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMAC HOLDINGS INC finden Sie auf Wallstreet Online.
